These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 18387968
21. Relationship between the role of the adenomatous polyposis coli protein in colon cancer and its contribution to cytoskeletal regulation. Näthke I. Biochem Soc Trans; 2005 Aug; 33(Pt 4):694-7. PubMed ID: 16042576 [Abstract] [Full Text] [Related]
22. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions. Sena P, Saviano M, Monni S, Losi L, Roncucci L, Marzona L, De Pol A. Cancer Lett; 2006 Sep 28; 241(2):203-12. PubMed ID: 16298038 [Abstract] [Full Text] [Related]
23. The third 20 amino acid repeat is the tightest binding site of APC for beta-catenin. Liu J, Xing Y, Hinds TR, Zheng J, Xu W. J Mol Biol; 2006 Jun 30; 360(1):133-44. PubMed ID: 16753179 [Abstract] [Full Text] [Related]
24. Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis. Menéndez M, González S, Obrador-Hevia A, Domínguez A, Pujol MJ, Valls J, Canela N, Blanco I, Torres A, Pineda-Lucena A, Moreno V, Bachs O, Capellá G. Gastroenterology; 2008 Jan 30; 134(1):56-64. PubMed ID: 18166348 [Abstract] [Full Text] [Related]
25. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. Breuhahn K, Singh S, Schirmacher P, Bläker H. J Pathol; 2008 Jul 30; 215(3):300-7. PubMed ID: 18491352 [Abstract] [Full Text] [Related]
26. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A. Anticancer Res; 2008 Jul 30; 28(5A):2613-23. PubMed ID: 19035286 [Abstract] [Full Text] [Related]
27. Examination of actin and microtubule dependent APC localisations in living mammalian cells. Langford KJ, Askham JM, Lee T, Adams M, Morrison EE. BMC Cell Biol; 2006 Jan 19; 7():3. PubMed ID: 16423286 [Abstract] [Full Text] [Related]
28. Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation. Schneikert J, Vijaya Chandra SH, Ruppert JG, Ray S, Wenzel EM, Behrens J. PLoS One; 2013 Jan 19; 8(7):e68072. PubMed ID: 23840886 [Abstract] [Full Text] [Related]
29. Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3. Ferrarese A, Marin O, Bustos VH, Venerando A, Antonelli M, Allende JE, Pinna LA. Biochemistry; 2007 Oct 23; 46(42):11902-10. PubMed ID: 17910481 [Abstract] [Full Text] [Related]
32. Expression of E-cadherin, beta-catenin and APC protein in canine colorectal tumours. Restucci B, Martano M, DE Vico G, Lo Muzio L, Maiolino P. Anticancer Res; 2009 Aug 23; 29(8):2919-25. PubMed ID: 19661296 [Abstract] [Full Text] [Related]
33. A common role for various human truncated adenomatous polyposis coli isoforms in the control of beta-catenin activity and cell proliferation. Chandra SH, Wacker I, Appelt UK, Behrens J, Schneikert J. PLoS One; 2012 Aug 23; 7(4):e34479. PubMed ID: 22509309 [Abstract] [Full Text] [Related]
38. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G, Ralhan R. Life Sci; 2008 Aug 29; 83(9-10):318-25. PubMed ID: 18662704 [Abstract] [Full Text] [Related]
39. Tumor-associated NH2-terminal fragments are the most stable part of the adenomatous polyposis coli protein and can be regulated by interactions with COOH-terminal domains. Li Z, Näthke IS. Cancer Res; 2005 Jun 15; 65(12):5195-204. PubMed ID: 15958564 [Abstract] [Full Text] [Related]
40. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA. Cancer Res; 2009 May 01; 69(9):3764-71. PubMed ID: 19383900 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]